SRT3109

CAS No. 1204707-71-0

SRT3109 ( SRT3109; SRT-3109 )

Catalog No. M17881 CAS No. 1204707-71-0

SRT3109 is a CXCR2 ligand used in the treatment of chemokine mediated diseases and conditions.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 167 In Stock
5MG 255 In Stock
10MG 380 In Stock
25MG 619 In Stock
50MG 861 In Stock
100MG 1152 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SRT3109
  • Note
    Research use only, not for human use.
  • Brief Description
    SRT3109 is a CXCR2 ligand used in the treatment of chemokine mediated diseases and conditions.
  • Description
    SRT3109 is a CXCR2 ligand. CXCR2 ligands are potent chemoattractants for neutrophils and play a key role in the emigration of neutrophils from the blood to sites of tissue inflammation. Moreover, CXCR2 signaling may also regulate neutrophil mobilization from the bone marrow. Deletion of the chemokine receptor CXCR2 prevents the recruitment of neutrophils into tissues and subsequent development of experimental Lyme arthritis.
  • Synonyms
    SRT3109; SRT-3109
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CXCR2
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    1204707-71-0
  • Formula Weight
    475.53
  • Molecular Formula
    C18H23F2N5O4S2
  • Purity
    98%
  • Solubility
    DMSO : ≥ 100 mg/mL; 210.29 mM
  • SMILES
    C[C@H]([C@H](CO)O)Nc1cc(nc(n1)SCc1c(c(ccc1)F)F)NS(=O)(=O)N1CCC1
  • Chemical Name
    N-(2-((2,3-difluorobenzyl)thio)-6-(((2R,3R)-3,4-dihydroxybutan-2-yl)amino)pyrimidin-4-yl)azetidine-1-sulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 2-DEOXYCYTIDINE-5-TR...

    2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE TRISODI Oxidation contributes to antibiotic lethality in stationary-phase mycobacteria.

  • Poricoic acid B

    Poricoic acid B shows inhibitory activity against TPA-induced ear inflammatory oedema.

  • Azido-PEG9-azide

    Azido-PEG9-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.